Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. / Hughes, D.; Bodger, K.; Kikuchi, T. et al.
Yn: Alimentary Pharmacology and Therapeutics, Cyfrol 30, Rhif 3, 01.08.2009, t. 265-274.
Yn: Alimentary Pharmacology and Therapeutics, Cyfrol 30, Rhif 3, 01.08.2009, t. 265-274.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Bodger, K, Kikuchi, T & Hughes, DA 2009, 'Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.', Alimentary Pharmacology and Therapeutics, cyfrol. 30, rhif 3, tt. 265-274. https://doi.org/10.1111/j.1365-2036.2009.04033.x
APA
Hughes, D., Bodger, K., Kikuchi, T., & Hughes, D. A. (2009). Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Alimentary Pharmacology and Therapeutics, 30(3), 265-274. https://doi.org/10.1111/j.1365-2036.2009.04033.x
CBE
Hughes D, Bodger K, Kikuchi T, Hughes DA. 2009. Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Alimentary Pharmacology and Therapeutics. 30(3):265-274. https://doi.org/10.1111/j.1365-2036.2009.04033.x
MLA
Hughes, D. et al. "Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.". Alimentary Pharmacology and Therapeutics. 2009, 30(3). 265-274. https://doi.org/10.1111/j.1365-2036.2009.04033.x
VancouverVancouver
Hughes D, Bodger K, Kikuchi T, Hughes DA. Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Alimentary Pharmacology and Therapeutics. 2009 Awst 1;30(3):265-274. doi: 10.1111/j.1365-2036.2009.04033.x
Author
RIS
TY - JOUR
T1 - Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.
AU - Hughes, D.
AU - Bodger, K.
AU - Kikuchi, T.
AU - Hughes, D.A.
PY - 2009/8/1
Y1 - 2009/8/1
KW - GASTROENTEROLOGY & HEPATOLOGY
KW - PHARMACOLOGY & PHARMACY
U2 - 10.1111/j.1365-2036.2009.04033.x
DO - 10.1111/j.1365-2036.2009.04033.x
M3 - Article
VL - 30
SP - 265
EP - 274
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
SN - 0269-2813
IS - 3
ER -